Glycolipid Presentation by CD1d
Glycolipid Presentation by CD1d
批准号:
8247813
负责人:
ALBERT S. BENDELAC
金额:
$132.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-15 至 2014-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Self and microbial glycosylceramides perform important immunological functions as NKT cell antigens presented by CD1d, a lipid-binding MHC-like molecule. These functions range from host defense against pathogens to the regulation of cancer rejection, autoimmunity and allergy. Further, synthetic glycosylceramides can be used as adjuvants of vaccines and can modulate, through the release of either Thl or Th2 cytokines, various disease conditions including diabetes, experimental allergic encephalomyelitis, lupus and cancer rejection. Other glycosylceramides elicit adaptive T cell responses that may be involved in Multiple Sclerosis. Thus, the program project uses glycosylceramides as a model antigen family to study glycolipid antigen presentation by CD1d molecules, with potential clinical applications, as well as fundamental issues in lipid transport and recognition.
A multidisciplinary approach encompassing glycolipid analytic and synthetic chemistry, protein expression, biophysics and structural biology, as well as cellular immunology and cell biology, has been assembled to identify NKT ligands from natural sources and study fundamental aspects of their immunobiology. The past funding period has produced landmark accomplishments in identifying key self and microbial NKT cell antigens, characterizing lipid transfer proteins essential for their presentation, elucidating their crystal structures and developing a panel of synthetic variants to study their cell biology and their functional impact in vaccine and immunomodulation. These approaches will be pursued with the goal of developing a basic understanding of the cell biology of lipid uptake, trafficking and loading, of the biophysical and structural aspects of their binding to protein receptors such as CD1d, TCR and other lipid binding proteins; and integrating this knowledge in vivo at the functional level during NKT cell mediated immune responses to infection or to synthetic adjuvants. The individual research projects are as follows. Project 1. Savage: Identification and synthesis of microbial NKT ligands and design of structural variants and conjugates to understand their functional properties. Project 2. Teyton: Biochemical, biophysical and structural aspects of lipid interaction with CD1d, TCR and other lipid binding or transfer protein. Project 3. Bendelac: Functions associated with NKT ligand recognition in vivo in mice and intracellular trafficking properties of glycosylceramides
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.molimm.2012.10.016
发表时间:
2013-09
期刊:
Molecular immunology
影响因子:
3.6
作者:
[Freigang S, Kain L, Teyton L]
通讯作者:
Teyton L
Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination.
新的NKT激动剂ABX196在预防性人类疫苗接种中的功效。
DOI:
10.1016/j.vaccine.2014.08.070
发表时间:
2014-10-21
期刊:
VACCINE
影响因子:
5.5
作者:
[Tefit, Josianne Nitcheu, Crabe, Sandrine, Orlandini, Bernard, Nell, Haylene, Bendelac, Albert, Deng, Shenglou, Savage, Paul B., Teyton, Luc, Serra, Vincent]
通讯作者:
Serra, Vincent
DOI:
10.1084/jem.20061568
发表时间:
2007-04-16
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Sagiv Y, Bai L, Wei DG, Agami R, Savage PB, Teyton L, Bendelac A]
通讯作者:
Bendelac A
DOI:
10.1039/c1ob06276j
发表时间:
2011-10-26
期刊:
Organic & biomolecular chemistry
影响因子:
3.2
作者:
[Deng S, Mattner J, Zang Z, Bai L, Teyton L, Bendelac A, Savage PB]
通讯作者:
Savage PB
DOI:
10.3390/molecules181215662
发表时间:
2013-12-16
期刊:
Molecules (Basel, Switzerland)
影响因子:
--
作者:
[Anderson BL, Teyton L, Bendelac A, Savage PB]
通讯作者:
Savage PB
共 6 条
Transcriptional Regulation of Innate-Like T Cells
-
批准号:10441712
-
项目类别:
-
资助金额:$53.32万
-
财政年份:2022
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Development of Intestinal Polyreactive IgA B Cells
-
批准号:10543053
-
项目类别:
-
资助金额:$49.84万
-
财政年份:2019
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Development of Intestinal Polyreactive IgA B Cells
-
批准号:10321246
-
项目类别:
-
资助金额:$49.84万
-
财政年份:2019
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Development of Intestinal Polyreactive IgA B Cells
-
批准号:10078246
-
项目类别:
-
资助金额:$49.84万
-
财政年份:2019
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Specificity of Intestinal Immunoglobulin A
-
批准号:9296031
-
项目类别:
-
资助金额:$48.94万
-
财政年份:2016
-
负责人:ALBERT S. BENDELAC
-
依托单位:
A common hematopoietic precursor to innate lymphoid cells
-
批准号:9312731
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:ALBERT S. BENDELAC
-
依托单位:
A common hematopoietic precursor to innate lymphoid cells
-
批准号:9110098
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:ALBERT S. BENDELAC
-
依托单位:
A common hematopoietic precursor to innate lymphoid cells
-
批准号:8612741
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Allergic inflammation in genetic models of lung ILC2 deficiency
-
批准号:8576628
-
项目类别:
-
资助金额:$37.07万
-
财政年份:2013
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Allergic inflammation in genetic models of lung ILC2 deficiency
-
批准号:8847790
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2013
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Control of lymphoid effector programs by the E3 ligase cullin 3
-
批准号:8651505
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2013
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Allergic inflammation in genetic models of lung ILC2 deficiency
-
批准号:8703783
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2013
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Control of lymphoid effector programs by the E3 ligase cullin 3
-
批准号:8811992
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2013
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Control of lymphoid effector programs by the E3 ligase cullin 3
-
批准号:8482507
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2013
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Administrative Core
-
批准号:7329685
-
项目类别:
-
资助金额:$6.48万
-
财政年份:2008
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Glycolipid Specific T Cell Responses
-
批准号:7329681
-
项目类别:
-
资助金额:$27.49万
-
财政年份:2008
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Glycolipid Presentation by CD1d
-
批准号:7010023
-
项目类别:
-
资助金额:$102.14万
-
财政年份:2003
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Glycolipid Presentation by CD1d
-
批准号:7301026
-
项目类别:
-
资助金额:$130.4万
-
财政年份:2003
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Glycolipid Presentation by CD1d
-
批准号:6838205
-
项目类别:
-
资助金额:$105.83万
-
财政年份:2003
-
负责人:ALBERT S. BENDELAC
-
依托单位:
Glycolipid Presentation by CD1d
-
批准号:7163441
-
项目类别:
-
资助金额:$102.04万
-
财政年份:2003
-
负责人:ALBERT S. BENDELAC
-
依托单位:
海外基金